Effect on Primary Sleep Disorders When Children With ADHD Are Administered Guanfacine Extended Release
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Objective: To evaluate children with ADHD and sleep problems with polysomnography (PSG) after guanfacine extended-release (GXR) administration. Method: Double-blind, randomized, placebo-controlled study was terminated early due to treatment-emergent concerns after enrolling 29 children aged 6 to 12 years. After >4 weeks dose adjustment and >1 week dose stabilization, 11 children received GXR and 16 controls underwent analyses with PSG. Results: Although GXR improved ADHD symptoms, the primary outcome variable, total sleep time, was shorter in contrast to placebo (−57.32, SD = 89.17 vs. +31.32, SD = 59.54 min, p = .005). Increased time awake after sleep onset per hour of sleep was the primary factor for the reduction. Although rapid eye movement (REM), non-REM, and N3/slow wave sleep times were reduced, these were proportional to the overall sleep reduction. Sedation was common with GXR (73% vs. 6%). Conclusion: Morning-administered GXR resulted in decreased sleep and may contribute to sedation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cortese, S., Faraone, S. V., Konofal, E., & Lecendreux, M. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181ac09c9 · Cited by 637
Fishman (2006) · doi:10.1097/01 · Cited by 547
Kelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., Sutton, V. K., Gonzales, J., Malcolm, S. K., Schuh, K. J., et al. (2004) · Pediatrics · doi:10.1542/peds.114.1.e1 · Cited by 464 · cited 1×
“Consistent with previously published data and prior pharmacologic studies (Kelsey et al., 2004; Leung & Lemay, 2003; Mattingly et al., 2012; Sallee, Kollins, & Wigal, 2012), there was a preponderance of ADHDcombined type in both groups (Table 1).”
ResultSallee, F. R., Mcgough, J., Wigal, T., Donahue, J., Lyne, A., & Biederman, J. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318191769e · Cited by 391
Biederman, J., Melmed, R. D., Patel, A., McBurnett, K., Konow, J., Lyne, A., Scherer, N., & for the SPD503 Study Group (2008) · Pediatrics · doi:10.1542/peds.2006-3695 · Cited by 317 · cited 8×
“As seen in previous double-blind randomized studies (Biederman et al., 2008; Newcorn et al., 2013; Sallee et al., 2012; Sallee, Lyne, et al., 2009; Sallee, McGough, et al., 2009), GXR improved both inattention and hyperactivity– impulsivity symptoms of ADHD.”
MethodResultInfluentialSallee, F. R., Lyne, A., Wigal, T., & McGough, J. J. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0080 · Cited by 306
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder
CONNOR, D. F., FLETCHER, K. E., & SWANSON, J. M. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199912000-00017 · Cited by 297
Van der Heijden, K. B., Smits, M. G., Someren, E. J. W. V., & Boudewijn Gunning, W. (2005) · Chronobiology International · doi:10.1081/cbi-200062410 · Cited by 269
Clonidine Extended-Release: In Attention-Deficit Hyperactivity Disorder
Croxtall, J. D. (2011) · Pediatric Drugs · doi:10.2165/11208100-000000000-00000 · Cited by 190
(2016) · doi:10.1037/t05638-000 · Cited by 142
Cited by
Politte, L. C., Scahill, L., Figueroa, J., McCracken, J. T., King, B., & McDougle, C. J. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0039-3 · Cited by 90
“However, a recent placebo-controlled study of GEXR in 29 children with ADHD and co-occurring sleep problems was terminated early after finding that GEXR was associated with decreased total sleep time on polysomnography compared with placebo [19].”
BackgroundCortese, S., Fusetto Veronesi, G., Gabellone, A., Margari, A., Marzulli, L., Matera, E., Petruzelli, M. G., Piarulli, F. M., Tarantino, F., Bellato, A., et al. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2353692 · Cited by 34
Li, Y., Gao, J., He, S., Zhang, Y., & Wang, Q. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0179-6 · Cited by 26
Luan, R., Mu, Z., Yue, F., & He, S. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00229 · Cited by 11
“Rugino (76) USA NCT01156051 √ Double NA 9.”
Metadata
- Authors
- Rugino, T. A.
- Venue
- Journal of Attention Disorders
- Publisher
- SAGE Publications
- Published
- 2014-11-06
- Volume
- 22
- Issue
- 1
- Pages
- 14-24
- ISSN
- 1087-0547 (ISSN-L)
- 1557-1246
- OpenAlex
- W2019708881
- Cited by
- 38
- References
- 13
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect on Primary Sleep Disorders When Children With ADHD Are Administered Guanfacine Extended Release. https://app.cochat.ai/papers/10.1177/1087054714554932
- The paper
- Rugino, T. A. (2018). Effect on Primary Sleep Disorders When Children With ADHD Are Administered Guanfacine Extended Release. Journal of Attention Disorders. https://doi.org/10.1177/1087054714554932
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.